Sernova Corp. (CVE:SVA) shares hit a new 52-week low on Wednesday . The company traded as low as C$0.16 and last traded at C$0.16, with a volume of 152927 shares changing hands. The stock had previously closed at C$0.17.

The firm has a market cap of $27.20 million and a price-to-earnings ratio of -7.17.

TRADEMARK VIOLATION NOTICE: This report was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this report on another publication, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this report can be read at https://theolympiareport.com/2019/03/15/sernova-sva-hits-new-1-year-low-at-0-16.html.

About Sernova (CVE:SVA)

Sernova Corp., a regenerative medicine company, engages in the development and commercializing of its proprietary Cell Pouch and associated technologies. The company's proprietary Cell Pouch and associated technologies include therapeutic cells and local immune protection. It focuses on developing medical devices and combination products for patients with chronic metabolic, neurological, and haematological diseases.

See Also: What type of investment options does a Roth IRA provide?

Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.